Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to drive advancements in genome engineering.
Market
Genetic Medicines
Location
Cambridge,
MA,
USA
Coinvestors
Abu Dhabi Investment Authority, Alaska Permanent Fund, Altitude Life Science Ventures, Artis Ventures, Cormorant Asset Management, Flagship Pioneering, Hanwha Impact Partners, Longevity Vision Fund, March Capital Partners, SALT Fund, SoftBank Vision Fund 2, T. Rowe Price Associates